Development of improved cholera vaccine based on subunit toxoid.
about
Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine PlatformEvaluation of TcpF-A2-CTB chimera and evidence of additive protective efficacy of immunizing with TcpF and CTB in the suckling mouse model of cholera.Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cellsIntestinal immune response to cholera toxin: dependence on route and dosage of antigen for priming and boosting.Protective effect of active immunization with purified Escherichia coli heat-labile enterotoxin in ratsAntigenic specificity of neutralizing antibody to cholera toxinProtection against experimental cholera by oral or parenteral immunizationFrom cholera to enterotoxigenic Escherichia coli (ETEC) vaccine developmentIntestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.Correlation between intestinal synthesis of specific immunoglobulin A and protection against experimental cholera in mice.Role of antibodies against biotype-specific Vibrio cholerae pili in protection against experimental classical and El Tor cholera.Immunization with cholera toxin B subunit induces high-level protection in the suckling mouse model of cholera.Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues.Induction of compartmentalized B-cell responses in human tonsilsSynergistic protective effect of antibodies against Escherichia coli enterotoxin and colonization factor antigens.Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin.Development of a vaccine against experimental cholera and Escherichia coli diarrheal disease.Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes.Cholera toxin as a mucosal adjuvant: effects of H-2 major histocompatibility complex and lps genes.Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans.Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21aEnterotoxigenic Escherichia coli diarrhea in an endemic area prepares the intestine for an anamnestic immunoglobulin A antitoxin response to oral cholera B subunit vaccination.Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.Mucosal antitoxin response in volunteers to immunization with a synthetic peptide of Escherichia coli heat-stable enterotoxinSaliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural diseaseEstablishment of an adult mouse model for direct evaluation of the efficacy of vaccines against Vibrio choleraeDifferential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses.Nanoparticle-detained toxins for safe and effective vaccination.Evaluation of recombinant forms of the shiga toxin variant Stx2eB subunit and non-toxic mutant Stx2e as vaccine candidates against porcine edema disease.Challenges in mucosal vaccines for the control of infectious diseases.Attenuated recombinant strains of Vibrio cholerae for oral immunization.Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoites.Protective effect of immunization of rats with holotoxin or B subunit of Escherichia coli heat-labile enterotoxin.Respective contributions to protection of primary and booster immunization with Escherichia coli heat-labile enterotoxin in rats.Oral enteric vaccines--clinical trials.Influence of route of administration on immediate and extended protection in rats immunized with Escherichia coli heart-labile enterotoxin.New knowledge in human milk immunoglobulin.Ion-Exchange Chromatography to Analyze Components of a Clostridium difficile Vaccine.
P2860
Q26784233-E8715C2A-A660-41FD-85EE-2596E2A53185Q31083435-C277E2A9-BE9F-4CE2-B783-9CB272BE34F2Q33623017-431CFC30-CB3F-4E77-8E23-004A66F39338Q33909821-F9A8CA27-5984-450C-AC36-EDFCAE4F8279Q34079512-AF55484E-A868-4289-8F85-57533138A188Q34085664-6E6888EB-E97A-4F53-96B8-A1684DB0045BQ34097649-C91B951D-D152-47AD-9237-D81400FF83D9Q34171594-AE10074E-7E2A-4E7E-88F2-7B8EEC0D43E8Q34225394-43F60A81-B627-4C4F-8401-BB5819174DCEQ34449031-CA32384D-8DAF-4833-BBF5-671B169A8789Q34530188-2353955A-7921-4D89-AA25-AAF0BB7B5DF8Q34611925-DE79D35E-2FCF-4CAD-8F1D-F8384E45E106Q35093806-B5732BB3-02FF-49FA-B4A3-CB1438D66CA5Q35391609-8990E891-22FE-407F-A0F9-DCD27747931FQ36334871-2567A860-00C3-4676-A542-8297A9B48183Q36336709-8217D94D-0572-4299-BCA5-47942583BBA2Q36446598-3F2CCAB3-6FE3-45D0-AC8D-823234A4A796Q36875506-5474E3EB-414B-4288-A7F9-A5FF2A657DDFQ36947860-759D1E88-A50D-4F1F-A6DF-50037A9489F7Q36974461-7F51EF8A-15E2-4D41-850F-C45BBF275073Q36982528-CD0E9D83-1A35-4B3A-A923-58AB0727C42CQ36992817-E1C1C6B2-BEA5-44EE-B069-508C3D2E9D54Q37018216-B5D6EF5C-0D0D-44B7-93D9-427C587720F8Q37053463-DB93675D-D8A5-4808-A9EB-0923A7AA0CDAQ37208278-82A484ED-2E21-4D74-AD7D-7185B45DE261Q37274863-FD159525-025A-4250-9A02-25D976C9E3DEQ37365152-421603FF-3163-4D25-80D4-5F14559058EFQ37426321-F535C808-D300-42FB-8469-94504F059275Q37618214-42454AB3-4D0A-4476-90CC-1AD5F98593B9Q38219010-AB515FA2-E07C-4D1D-B57D-34B9586A2130Q38616504-A65E0140-88F1-45B9-96D8-997DADC80F0AQ40159003-329A8D9A-E219-4758-928F-91289F3D3D08Q40615931-4759B175-CD12-4C0C-8598-D18C55E46D60Q40616002-560EDFB0-FEF1-48E3-BD72-F74883327FDFQ40744054-F733FC06-FB26-48BA-802F-38DFAB9AE0F5Q41152786-ABEC78BE-8893-4522-95EB-A95684A21433Q44098815-95E597F7-3092-4B1E-96A6-58272040BC97Q51581444-3075C47D-7C6A-4529-B584-0A7A0A9A66E1
P2860
Development of improved cholera vaccine based on subunit toxoid.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Development of improved cholera vaccine based on subunit toxoid.
@en
Development of improved cholera vaccine based on subunit toxoid.
@nl
type
label
Development of improved cholera vaccine based on subunit toxoid.
@en
Development of improved cholera vaccine based on subunit toxoid.
@nl
prefLabel
Development of improved cholera vaccine based on subunit toxoid.
@en
Development of improved cholera vaccine based on subunit toxoid.
@nl
P2093
P356
P1433
P1476
Development of improved cholera vaccine based on subunit toxoid.
@en
P2093
Fall-Persson M
Lundbeck H
Lönnroth I
P2888
P304
P356
10.1038/269602A0
P407
P577
1977-10-01T00:00:00Z
P6179
1000655776